More than 90% of nurses in Michigan believe that understaffing is negatively affecting the quality of care they’re able to provide, according to a new report. The percentage of respondents who know of a patient death being caused by nurses being assigned too many patients nearly doubled in the past seven years — from 22% in 2016 to 42% in 2023.
Gilead Sciences is building up its autoimmune disease drug pipeline by turning to EVOQ Therapeutics, a startup with technology that takes a novel approach to restoring immune tolerance. For EVOQ, the Gilead deal is its second with a big pharma company.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The FDA approved Nexlizet, according to an entry in its database of approved drugs. The new drug combines the active ingredient of Nexletol - which the FDA approved last week - with a generic non-statin drug, ezetimibe.
The drug, Nexletol, is designed for use with maximally tolerated statins for lowering LDL cholesterol in patients with heterozygous familial hypercholesterolemia and atherosclerotic cardiovascular disease.
The company plans to launch its prostate cancer test next year and has several papers it will to submit to journals in the next four to six months.
Don't mistake Stryker's latest $500 million deal in the spine market as a simple tuck-in acquisition, says one analyst while another says it could help Stryker give Medtronic a run for its money.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The new fund is the single largest ever raised in Michigan eclipsing the earlier $220 million Arboretum IV fund raised in 2015.
Best Buy's acquisition of CST builds on the company's $800 million purchase of Great Call last year, which served to steer the company's business in a strategic direction towards providing technology products, services and solutions to the aging population.
Tetra Discovery Partners announced the initiation of a Phase II study of BPN14770, which targets phosphodiesterase-4D, or PDE4D. The trial is expected to enroll about 255 patients at 60 sites in the US.
The Ann Arbor, Michigan-based startup intends to use the funding to secure FDA clearance of its first product, which works to detect the emergence of hemodynamic instability.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Visits to three health systems — Mercy Health in Grand Rapids, Michigan; Henry Ford Health System in Detroit; and OSF HealthCare in Peoria, Illinois — showcase how they're thinking creatively about simulation, startups, 3D printing and more.
A new partnership between DMC and Ford Motor Company's non-emergency medical transportation service, Ford GoRide, enables patients with mobility challenges to get to and from appointments at specific medical facilities.
Analysts say that Stryker's purchase of a small but fast-growing public company in the complex spine market should help its own struggling spine business.
Through GM's ConnectedCare plan, nearly 24,000 General Motors salaried employees and their families in southeastern Michigan will be able to access Henry Ford providers. Employees can select the plan during the company's open enrollment this fall, and service will officially start at the beginning of 2019.
Ford's GoRide program through its Smart Mobility division represents a new kind of business moving into the non-emergency medical transportation business. Could other car manufacturers follow?